Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982;13(Suppl 2):305S–307S. doi: 10.1111/j.1365-2125.1982.tb01931.x

The influence of beta-adrenoceptor blockade on left ventricular function.

B Hahn, B E Strauer
PMCID: PMC1402147  PMID: 6125181

Abstract

1 This study was designed to compare in a randomized cross-over trial pindolol, a beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity and metoprolol, a cardioselective beta-adrenoceptor blocker lacking sympathomimetic activity in hypertensives with incipient heart failure. Cardiac function was investigated by M-Mode and 2D-echo-cardiography. 2 Both pindolol and metoprolol in equipotent doses lowered blood pressure to the same extent. 3 There was no difference in overall left ventricular function in ventricular geometry or in wall dynamics after either drug. 4 In comparison to metoprolol, pindolol produced less reduction in resting heart rate, cardiac index and ejection velocity reflecting the intrinsic sympathomimetic activity of the drug.

Full text

PDF
305S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blinks J. R. Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):673–685. doi: 10.1111/j.1749-6632.1967.tb41237.x. [DOI] [PubMed] [Google Scholar]
  2. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frishman W., Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects. Am Heart J. 1979 Jun;97(6):797–807. doi: 10.1016/0002-8703(79)90016-4. [DOI] [PubMed] [Google Scholar]
  4. Jorgensen C. R., Wang K., Wang Y., Gobel F. L., Nelson R. R., Taylor H. Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise. Circulation. 1973 Dec;48(6):1173–1182. doi: 10.1161/01.cir.48.6.1173. [DOI] [PubMed] [Google Scholar]
  5. Koch-Weser J., Frishman W. H. beta-Adrenoceptor antagonists: new drugs and new indications. N Engl J Med. 1981 Aug 27;305(9):500–506. doi: 10.1056/NEJM198108273050907. [DOI] [PubMed] [Google Scholar]
  6. McNeil J. J., Louis W. J. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol. 1979;8(Suppl 2):163S–166S. [PMC free article] [PubMed] [Google Scholar]
  7. Opie L. H. Drugs and the heart. Lancet. 1980 Mar 29;1(8170):693–698. [PubMed] [Google Scholar]
  8. Svendsen T. L., Hartling O., Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol. 1979 May 21;15(4):223–228. doi: 10.1007/BF00618509. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES